project id: TCGA-LGG; case submitter id: TCGA-P5-A5F0; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.77; rna integrity number: 8.9; age at index: 33; days to birth: -12157; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1979; age at diagnosis: 12157; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 287.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9450/3; primary diagnosis: Oligodendroglioma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: No; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 62; initial weight: 110.0; sample id: bc45dd63-bb3a-474b-9ce9-ee9d7bd3c2c2; sample submitter id: TCGA-P5-A5F0-01A; portion id: f495a8ac-f2d3-44ab-8276-2fd0d5900326; portion submitter id: TCGA-P5-A5F0-01A-11; slide id: d922089b-477d-416a-9912-befc81d2695c; slide submitter id: TCGA-P5-A5F0-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 50.0; percent tumor cells: 40.0; percent tumor nuclei: 80.0; section location: TOP;